Works matching IS 13524585 AND DT 2015 AND VI 21 AND IP 10

Results: 16

The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level: Commentary.
Published in:
2015
By:
- Hutchinson, Michael
Publication type:
Opinion
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level—NO.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1240, doi. 10.1177/1352458515589774
By:
- Arrambide, Georgina;
- Espejo, Carmen;
- Tintore, Mar
Publication type:
Article
Educational attainment and cognitive status in MS: Reading, writing, and economics.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1221, doi. 10.1177/1352458515584417
By:
- Sumowski, James F.
Publication type:
Article
Cognitive reserve in multiple sclerosis: Protective effects of education.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1312, doi. 10.1177/1352458515581874
By:
- Martins Da Silva, Ana;
- Cavaco, Sara;
- Moreira, Inês;
- Bettencourt, Andreia;
- Santos, Ernestina;
- Pinto, Cláudia;
- Gonçalves, Alexandra;
- Coutinho, Ester;
- Samões, Raquel;
- Dias, Cláudia C.;
- Teixeira-Pinto, Armando;
- Da Silva, Berta Martins;
- Montalban, Xavier
Publication type:
Article
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1223, doi. 10.1177/1352458515581441
By:
- Steinman, Lawrence
Publication type:
Article
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level – YES.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1239, doi. 10.1177/1352458515578773
By:
- Salzer, Jonatan
Publication type:
Article
A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1332, doi. 10.1177/1352458515572405
By:
- Gich, Jordi;
- Freixanet, Jordi;
- García, Rafael;
- Vilanova, Joan Carles;
- Genís, David;
- Silva, Yolanda;
- Montalban, Xavier;
- Ramió-Torrentà, Lluís
Publication type:
Article
Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1322, doi. 10.1177/1352458514563591
By:
- Goodman, Andrew D.;
- Bethoux, Francois;
- Brown, Theodore R.;
- Schapiro, Randall T.;
- Cohen, Ron;
- Marinucci, Lawrence N.;
- Henney, Herbert R.;
- Blight, Andrew R.;
- Agius, M.;
- Arnason, B. G. W.;
- Bethoux, F. A.;
- Bever, C. T.;
- Bowen, J. D.;
- Brown, T. R.;
- Dietrich, D. W.;
- Edwards, K.;
- Freedman, M. S.;
- Freedman, M.;
- Kachuck, N. J.;
- Kaufman, M. D.
Publication type:
Article
What drives MRI-measured cortical atrophy in multiple sclerosis?
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1280, doi. 10.1177/1352458514562440
By:
- Popescu, V.;
- Klaver, R.;
- Voorn, P.;
- Galis-de Graaf, Y.;
- Knol, D. L.;
- Twisk, J. W. R.;
- Versteeg, A.;
- Schenk, G. J.;
- Van der Valk, P.;
- Barkhof, F.;
- De Vries, H. E.;
- Vrenken, H.;
- Geurts, J. J. G.
Publication type:
Article
Interferon-beta affects mitochondrial activity in CD4<sup>+</sup> lymphocytes: Implications for mechanism of action in multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1262, doi. 10.1177/1352458514561909
By:
- Haghikia, Aiden;
- Faissner, Simon;
- Pappas, Derek;
- Pula, Bartosz;
- Akkad, Denis A.;
- Arning, Larissa;
- Ruhrmann, Sabrina;
- Duscha, Alexander;
- Gold, Ralf;
- Baranzini, Sergio E.;
- Malhotra, Sunny;
- Montalban, Xavier;
- Comabella, Manuel;
- Chan, Andrew
Publication type:
Article
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1271, doi. 10.1177/1352458514561908
By:
- Checa, Antonio;
- Khademi, Mohsen;
- Sar, Daniel G.;
- Haeggström, Jesper Z.;
- Lundberg, Jon O.;
- Piehl, Fredrik;
- Olsson, Tomas;
- Wheelock, Craig E.
Publication type:
Article
Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1291, doi. 10.1177/1352458514561907
By:
- Masera, S.;
- Cavalla, P.;
- Prosperini, L.;
- Mattioda, A.;
- Mancinelli, C. R.;
- Superti, G.;
- Chiavazza, C.;
- Vercellino, M.;
- Pinessi, L.;
- Pozzilli, C.
Publication type:
Article
A new cognitive rehabilitation programme for patients with multiple sclerosis: the ‘MS-line! Project’.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1344, doi. 10.1177/1352458514561905
By:
- Gich, Jordi;
- Freixenet, Jordi;
- Garcia, Rafael;
- Vilanova, Joan Carles;
- Genís, David;
- Silva, Yolanda;
- Montalban, Xavier;
- Ramió-Torrentà, Lluís
Publication type:
Article
The changing face of multiple sclerosis: Prevalence and incidence in an aging population.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1244, doi. 10.1177/1352458514561904
By:
- Solaro, C.;
- Ponzio, M.;
- Moran, E.;
- Tanganelli, P.;
- Pizio, R.;
- Ribizzi, G.;
- Venturi, S.;
- Mancardi, G. L.;
- Battaglia, M. A.
Publication type:
Article
MS in prose, poems and drama.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1298, doi. 10.1177/1352458514560929
By:
- Riem, Philine;
- Karenberg, Axel
Publication type:
Article
Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2015, v. 21, n. 10, p. 1251, doi. 10.1177/1352458514561906
By:
- Hinsinger, G.;
- Galéotti, N.;
- Nabholz, N.;
- Urbach, S.;
- Rigau, V.;
- Demattei, C.;
- Lehmann, S.;
- Camu, W.;
- Labauge, P.;
- Castelnovo, G.;
- Brassat, D.;
- Loussouarn, D.;
- Salou, M.;
- Laplaud, D.;
- Casez, O.;
- Bockaert, J.;
- Marin, P.;
- Thouvenot, E.
Publication type:
Article